Trial Profile
Long term efficacy and safety of telbivudine and entecavir in HBeAg positive patients with chronic hepatitis B
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2016
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Telbivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 30 Nov 2016 New trial record